These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2685035)

  • 1. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure.
    Clabots CR; Gerding SJ; Olson MM; Peterson LR; Gerding DN
    J Clin Microbiol; 1989 Oct; 27(10):2386-7. PubMed ID: 2685035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples.
    Tyrrell KL; Citron DM; Leoncio ES; Merriam CV; Goldstein EJ
    J Clin Microbiol; 2013 Sep; 51(9):3094-6. PubMed ID: 23804392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screen for Clostridium difficile in the vagina: an out-patient study using and comparing selective media.
    Thirkell D; Thakker B; Herriot A; Armitt I
    Antonie Van Leeuwenhoek; 1984; 50(4):355-60. PubMed ID: 6524911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Clostridium difficile from faecal specimens--a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar.
    Carson KC; Boseiwaqa LV; Thean SK; Foster NF; Riley TV
    J Med Microbiol; 2013 Sep; 62(Pt 9):1423-1427. PubMed ID: 23579394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.
    Hink T; Burnham CA; Dubberke ER
    Anaerobe; 2013 Feb; 19():39-43. PubMed ID: 23247066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile from healthy food animals: optimized isolation and prevalence.
    Thitaram SN; Frank JF; Lyon SA; Siragusa GR; Bailey JS; Lombard JE; Haley CA; Wagner BA; Dargatz DA; Fedorka-Cray PJ
    J Food Prot; 2011 Jan; 74(1):130-3. PubMed ID: 21219775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.
    Willey SH; Bartlett JG
    J Clin Microbiol; 1979 Dec; 10(6):880-4. PubMed ID: 521486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of culture based methods for the isolation of Clostridium difficile from stool samples in a research setting.
    Lister M; Stevenson E; Heeg D; Minton NP; Kuehne SA
    Anaerobe; 2014 Aug; 28():226-9. PubMed ID: 25038491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserine-cefoxitin-fructose agar (CCFA).
    Foster NF; Riley TV
    Pathology; 2012 Jun; 44(4):354-6. PubMed ID: 22531346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.
    Arroyo LG; Rousseau J; Willey BM; Low DE; Staempfli H; McGeer A; Weese JS
    J Clin Microbiol; 2005 Oct; 43(10):5341-3. PubMed ID: 16208013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified procedure for the routine isolation of Clostridium difficile from faeces.
    Borriello SP; Honour P
    J Clin Pathol; 1981 Oct; 34(10):1124-7. PubMed ID: 7031097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective enrichment broth culture for detection of Clostridium difficile and associated cytotoxin.
    Buchanan AG
    J Clin Microbiol; 1984 Jul; 20(1):74-6. PubMed ID: 6746889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of community carriage rates of Clostridium difficile and Hungatella hathewayi in healthy volunteers from four regions of England.
    Manzoor SE; McNulty CAM; Nakiboneka-Ssenabulya D; Lecky DM; Hardy KJ; Hawkey PM
    J Hosp Infect; 2017 Oct; 97(2):153-155. PubMed ID: 28549779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cycloserine-cefoxitin-fructose agar and cycloserine-cefoxitin-fructose broth for recovery of Clostridium difficile from environmental sites.
    Clabots CR; Bettin KM; Peterson LR; Gerding DN
    J Clin Microbiol; 1991 Nov; 29(11):2633-5. PubMed ID: 1774277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and quantitation of Clostridium difficile in aqueous and fecal matter using two types of selective media.
    Housman ST; Banevicius MA; Lamb LM; Nicolau DP
    J Microbiol Immunol Infect; 2016 Jun; 49(3):445-7. PubMed ID: 26198865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.
    Rogers DS; Kundrapu S; Sunkesula VC; Donskey CJ
    J Clin Microbiol; 2013 Oct; 51(10):3421-2. PubMed ID: 23926162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Clostridium difficile in stool specimens by culture-enhanced gas-liquid chromatography.
    Johnson LL; McFarland LV; Dearing P; Raisys V; Schoenknecht FD
    J Clin Microbiol; 1989 Oct; 27(10):2218-21. PubMed ID: 2685021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective broth for Clostridium difficile.
    Carroll SM; Bowman RA; Riley TV
    Pathology; 1983 Apr; 15(2):165-7. PubMed ID: 6888964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the chromogenic agar chromID C. difficile.
    Eckert C; Burghoffer B; Lalande V; Barbut F
    J Clin Microbiol; 2013 Mar; 51(3):1002-4. PubMed ID: 23269743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.